Roche Holding | ROG - Przychody Ze Sprzedaży





Obroty Zmiana Data
AbbVie USD 17.4B 410M 2026-09
Alcon AG USD 2.72B 60M 2026-09
Almirall EUR 602.71M 55.09M 2026-06
Amgen USD 10.4B 300M 2026-09
AstraZeneca USD 16.21B 830M 2026-09
Bayer EUR 10.05B 820M 2026-09
Biogen USD 2.8B 60M 2026-09
Bristol-Myers Squibb USD 13.07B 100M 2026-09
Eli Lilly USD 24.4B 1.43B 2026-09
Fresenius EUR 5.88B 70M 2026-09
Fresenius Medical Care EUR 4.94B 80M 2026-09
Genmab DKK 1.16B 259M 2026-06
Gilead Sciences USD 8.3B 500M 2026-09
GlaxoSmithKline GBP 8.89B 480M 2026-09
GRIFOLS EUR 2.04B 170M 2026-09
Hikma Pharmaceutical USD 1.69B 863M 2025-12
Lakefront Biotherapeutics EUR 7.11M 5M 2026-09
Lonza CHF 3.58B 63M 2025-06
Merck EUR 5.63B 200M 2026-09
Merck USD 18.1B 1.5B 2026-09
Novartis USD 14.52B 112M 2026-09
Orion EUR 542.2M 20.6M 2026-09
Pfizer USD 16.6B 1.57B 2026-09
Philips EUR 4.4B 40M 2026-09
Recordati EUR 672M 9.35M 2026-09
Regeneron Pharmaceuticals USD 5.12B 830M 2026-09
Roche Holding CHF 30.36B 14.71B 2026-06
Sanofi EUR 14.44B 2.49B 2026-09
UCB EUR 4.25B 764M 2025-12